- Home
- ATOS vs ECBK Comparison
ATOS vs ECBK Comparison
Compare ATOS & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ECBK
- Stock Information
- Founded
- ATOS 2009
- ECBK 1919
- Country
- ATOS United States
- ECBK United States
- Employees
- ATOS N/A
- ECBK N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ECBK Banks
- Sector
- ATOS Health Care
- ECBK Finance
- Exchange
- ATOS Nasdaq
- ECBK Nasdaq
- Market Cap
- ATOS 130.5M
- ECBK 151.0M
- IPO Year
- ATOS 2012
- ECBK N/A
- Fundamental
- Price
- ATOS $0.98
- ECBK $15.12
- Analyst Decision
- ATOS Strong Buy
- ECBK
- Analyst Count
- ATOS 3
- ECBK 0
- Target Price
- ATOS $6.25
- ECBK N/A
- AVG Volume (30 Days)
- ATOS 1.3M
- ECBK 10.3K
- Earning Date
- ATOS 11-11-2025
- ECBK 10-24-2025
- Dividend Yield
- ATOS N/A
- ECBK N/A
- EPS Growth
- ATOS N/A
- ECBK 52.06
- EPS
- ATOS N/A
- ECBK 0.64
- Revenue
- ATOS N/A
- ECBK $27,795,000.00
- Revenue This Year
- ATOS N/A
- ECBK N/A
- Revenue Next Year
- ATOS N/A
- ECBK N/A
- P/E Ratio
- ATOS N/A
- ECBK $23.65
- Revenue Growth
- ATOS N/A
- ECBK 12.29
- 52 Week Low
- ATOS $0.55
- ECBK $12.56
- 52 Week High
- ATOS $1.66
- ECBK $17.33
- Technical
- Relative Strength Index (RSI)
- ATOS 57.15
- ECBK 31.58
- Support Level
- ATOS $0.86
- ECBK $14.99
- Resistance Level
- ATOS $1.29
- ECBK $15.70
- Average True Range (ATR)
- ATOS 0.08
- ECBK 0.25
- MACD
- ATOS 0.01
- ECBK -0.06
- Stochastic Oscillator
- ATOS 38.23
- ECBK 8.78
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.